| Charles A Denton, MD | |
|
988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 | |
| (402) 559-4020 | |
| (402) 559-9659 |
| Full Name | Charles A Denton |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 988102 Nebraska Medical Ctr, Omaha, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740217496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 14101 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles A Denton, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-4020 | Charles A Denton, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-4020 |
News Archive
Seattle Genetics, Inc. (NASDAQ:SGEN), announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration agreement with MedImmune, LLC, a wholly owned subsidiary of AstraZeneca. The milestone was triggered by MedImmune's initiation of a phase I clinical trial of MEDI-547, its anti-EphA2 ADC for solid tumors.
eZono AG, a private corporation designing, developing and distributing state of the art tablet ultrasound systems, today announced it received 510(k) clearance from the FDA for its eZono 4000 dedicated procedural guidance system with eZGuide technology, providing any plane freehand navigation.
Air quality in homes, offices, and other indoor spaces is becoming a major health concern, particularly in developed countries where people often spend more than 90% of their time indoors. Surprisingly, indoor air has been reported to be as much as 12 times more polluted than outdoor air in some areas. Indoor air pollutants emanate from paints, varnishes, adhesives, furnishings, clothing, solvents, building materials, and even tap water.
People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax's lead product entinostat, a novel inhibitor of histone deacetylases (HDAC), and anastrozole, an aromatase inhibitor, in postmenopausal women with operable triple negative breast cancer to evaluate biomarkers and surrogates for response.
› Verified 4 days ago
Tyler Christian Pedersen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Chad E Branecki, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 988095 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-9800 Fax: 402-559-9840 | |
Dr. Robert S. Devin, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 6901 N 72nd St, Omaha, NE 68122 Phone: 402-572-2225 Fax: 402-572-4974 | |
Dr. Kevin Michael Montgomery, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Ryan Jorgenson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Phillip Marshall Stratton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 | |
Dr. James E Quinn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 |